Interim Analysis from the OPTIC Trial - A Dose-Ranging Study of 3 Starting Doses of Ponatinib

Artículo de revista

2020

Clinical Lymphoma Myeloma & Leukemia Volumen: 20 Páginas: S234-S234 Suplemento: 1 Abstract de reunión: CML-114 Sep 2020

2152-2650

Cortés, Jorge

Lomaia, Elza

Turkina, Anna

Moiraghi, Beatriz

Undurraga Sutton, María Soledad

Pavlovsky, Carolina

Rojas, Christine

Chuah, Charles

Arthur, Christopher

Apperley, Jane

Kim, Dong-Wook

Hochhaus, Andreas

Rousselot, Philippe

Rosti, Gianantonio

Mauro, Michael

Lipton, Jeffrey

Naranjo, Daniel

Liu, Guohui

Srivastava, Shouryadeep

Deininger, Michael